Technical and Biological Biases in Bulk Transcriptomic Data Mining for Cancer Research
2025

Biases in Transcriptomic Data Mining for Cancer Research

publication Evidence: moderate

Author Information

Author(s): Hengrui Liu, Yiying Li, Miray Karsidag, Tiffany Tu, Panpan Wang

Primary Institution: Cancer Research Institute, Jinan University, Guangzhou, China

Hypothesis

What are the technical and biological biases in bulk transcriptomic data mining for cancer research?

Conclusion

The study highlights the importance of recognizing and addressing biases in transcriptomic data mining to enhance the reliability and impact of cancer research.

Supporting Evidence

  • Transcriptomic data provides crucial insights into gene expression patterns and disease mechanisms.
  • Technical biases include issues related to microarray, RNA-seq, and nanopore sequencing methods.
  • Biological biases arise from factors like tumor heterogeneity and sample purity.
  • Misinterpretations often occur when correlational data is erroneously assumed to imply causality.

Takeaway

This paper talks about the problems researchers face when analyzing cancer data, like mistakes that can happen because of how the data is collected and understood.

Methodology

The paper reviews existing literature on transcriptomic data mining and discusses various biases encountered in the analysis.

Potential Biases

Potential misinterpretations of data due to technical and biological biases, such as tumor heterogeneity and sample purity.

Limitations

The study primarily focuses on biases and does not provide new experimental data or solutions to overcome these biases.

Digital Object Identifier (DOI)

10.7150/jca.100922

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication